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Abstract: The aim of this study was to examine the influence of trivalent chromium ions (Cr3+) supplementation on antioxidant status
and immune defense of rats. During the 30 days of the experiment, the male rats (n = 10 per group) were supplemented with CrCl3,
dissolved in distilled drinking water in doses of 0, 70, or 140 µg Cr3+/dm3. Next, the contents of hydroperoxides of lipids (HPL) and
thiobarbituric acid reactive substances (TBARS) in plasma were determined, as well as the activity of superoxide dismutase (SOD),
catalase (CAT), glutathione peroxidase (GPx), glutathione reductase (GR), and reduced glutathione (GSH) in erythrocytes. Lysozymic
and bactericidal activities of blood serum were also determined. Results of the experiment indicated that 140 µg Cr3+/dm3 increased
HPL concentration by 22.1%, while the dose of 70 µg Cr3+/dm3 decreased concentration of TBARS by 20.3% (P ≤ 0.05) in comparison
with the control. Activity of SOD in rats supplied with both doses of Cr3+ significantly decreased, whereas activity of CAT, GPx, and GR
significantly increased, similar to lysozymic and bactericidal activity. In general, the obtained results showed that a diet with chromium
supplementation can strengthen the main mechanisms of lipid peroxidation defense by stimulation of enzyme activity of the antioxidant
system and natural resistance factors.
Key words: Antioxidant enzymes, bactericide, lipid peroxidation defense, lysozymic, rats

1. Introduction
Chromium (Cr) is a metallic element that exists in
many chemical valence states, but the most stable forms
occurring in the environment are the 0 valence state (metal
and alloys), trivalent chromium [Cr(III)], and hexavalent
chromium [Cr(VI)]. Among them, the trivalent form of Cr
is most abundant in nature, forming stable complexes with
both organic and inorganic ligands. Chromium(III) can
be found in drinking water as well as in most fresh foods,
including bread, meat, and vegetables (1–3); however, the
bioeffectiveness of it is still being discussed. On one hand,
Cr(III) is widely used in tanning industrial processes and
therefore many epidemiological studies point to frequent
health problems such as cancer, dermatitis, asthma,
chronic bronchitis, hypertension, chromosomal abrasion,
back pains, metabolic syndrome, hemoglobin changes, and
DNA detriment in lymphocytes in populations chronically
exposed to Cr(III) (2,4,5). On the other hand, Cr(III) is
considered to be relatively nontoxic and, moreover, it is
widely accepted as an essential microelement in animal
and human nutrition (1,3,5–7). Simultaneously, it seems
that its supplementation in basal diets affects the other
elements, with a synergistic effect on zinc levels but an
* Correspondence: rzlis@cyf-kr.edu.pl
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antagonist effect on copper levels (8). The World Health
Organization (7) and the European Food Safety Authority
(1) estimated that the human daily intake of Cr(III)
amounts to about 4.1 µg kg body weight–1 day–1; however,
there is a large margin of safety of 4–5 orders of magnitude
between the daily intake and “the No-Observed-AdverseEffect Level”. Furthermore, Cr(III) is very poorly absorbed
via the gastrointestinal tract (0.4% to 2.8%) in both rats
and humans (1). Therefore, many authors pay attention to
the potential danger of chromium deficiency, which can
cause intolerance and inability to utilize glucose for energy
(diabetic and diabetic-like states), cardiovascular disease
(increased aortic plaque formation and disturbance of
hematological parameters), elevated blood lipids and high
free fatty acid levels, low respiratory quotient, abnormalities
of nitrogen metabolism, impaired growth, and decreased
fertility and longevity in both humans and animals (5,6).
These effects can stem from the fact that Cr3+ was proven
to have dual properties as an antioxidant and prooxidant
in the organism (4,9,10). However, the prooxidant effect
of Cr(III), which involves the reduction of Cr(III) into
Cr(II) (5,11,12) and causes lipid peroxidation (10,13,14),
is known, as well. In response to this process, antioxidant
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defense mechanisms using superoxide dismutase (SOD)
and reduced glutathione (GSH) (15,16) are activated.
Trivalent chromium ions (Cr3+) are also regulators of
the immune system and play an important role both in
immune-stimulatory and immunosuppressive processes.
They influence T and B lymphocytes, macrophages,
production of cytokines, and immune response in humans
and animals (17,18).
Because trivalent chromium bioactivity is still fairly
unknown and little discussed, this study was designed
to examine the influence of trivalent chromium ion
supplementation (Cr3+) on antioxidant status and immune
defense of the blood plasma of rats.
2. Materials and methods
2.1. Experimental design
Thirty male, 6-week-old, white laboratory Wistar rats
were used in the experiment, conducted in compliance
with agreement No. 21 of the Bioethical Commission
of the Institute of Animal Biology NAAS (06.01.2010).
During a 2-week acclimation period the animals were
housed in individual cages at an animal facility in rooms
maintained at 21 ± 1.5 °C and 65% humidity with a 12-h
photoperiod, and they were fed a diet (Harlan Teklad LM485 rodent diet) that consisted of 64% saccharose, 20%
casein, 5% maize oil, and recommended doses of vitamins

and microelements (Table 1). The rats were allowed to eat
and drink distilled water ad libitum. During this phase of
study, daily food and water intakes were established at 15
g diet/day and 20 mL/day, respectively. The Cr content
in fodder was measured by means of atomic absorption
spectrophotometer and established as 128 ± 26.5 µg/kg
(i.e. 14.8 ± 3.06 µg/kg body weight).
After the acclimation period, experimental animals
were weighed, and because there were no significant
differences in average body weights (mean: 130 ± 1.9 g),
the animals were divided into 3 groups (n = 10). During
30 days of experiment, rats in individual groups were
supplemented with Cr(III) in the form of chromium
chloride (CrCl3, Sigma Aldrich) dissolved in distilled
drinking water in doses of 0, 70, or 140 µg Cr3+/dm3, i.e. 0,
11, and 22 µg Cr3+/day at daily water consumption of 20 ±
4.0 mL per rat.
After a 30-day experimental period, animals were ether
anesthetized, blood samples were taken and centrifuged
for 15 min at 3000 rpm, and plasma and erythrocytes
samples were stored frozen at –20 °C following analyses.
The contents of hydroperoxides of lipids (HPLs) and
thiobarbituric acid reactive substances (TBARS) in plasma;
SOD, catalase (CAT), glutathione peroxidase (GPx),
and GSH contents in erythrocytes; and lysozymic and
bactericidal activities of blood serum were determined.

Table 1. The doses of vitamins and microelements in diets of rats during the experiment.
Vitamin

Dose
(mg/kg diet)

Mineral

Dose
(mg/kg diet)

Alpha-tocopherol

110

CaHPO4

30,000

Choline chloride

1650

NaCl

4000

D-Calcium pantothenate

66

MgCl2

5000

Inositol

110

ZnCO3

45

Menadione

49.5

MnCO3

90

Niacin

99

KІO3

1.75

PABA

110

CuCO3Cu(OH)2.H2O

12.5

Pyridoxine HCl

22

Nа2SeO3

0.22

Riboflavin

22

FeCl2.4H2O

71.175

Thiamin HCl

22

Vitamin A acetate

19,800 units

Calciferol (D2)

2200 units

Biotin

0.44

Folic acid

1.98

Vitamin B12

0.33
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2.2. Processing
2.2.1. Concentration of HPLs
Determination of HPLs in biological material (plasma
samples) was achieved by precipitating proteins with a
solution of trichloroacetic acid and lipid extraction by
ethanol followed by interaction of the studied extracts with
ammonium thiocyanate (19). HPLs were determined in the
following way: 1.5 mL of ethanol extract was completed by
ethanol to 2.7 mL and shaken, and 0.02 mL of concentrated
HCl and 0.03 mL of 1% salt Mora solution in 3% HCl
solution were added to it. The mixture was shaken, and after
30 s, 0.2 mL of 20% solution of ammonium thiocyanate
was added; afterwards, a raspberry color appeared. Optical
density measurements were carried out within 10 min
after the addition of ammonium thiocyanate by means
of a spectrophotometer at the wavelength of 480 nm. The
control sample was prepared like a research sample, but
instead of blood plasma, 0.2 mL of bidistilled water was
taken. The content of HPLs in biological material was
expressed in terms of optical density at 480 nm in 1 mL of
plasma (plasma ΔD480/mL).
2.2.2. Concentration of TBARS in plasma
The concentration of TBARS, an indicator of lipid
peroxidation in plasma and tissues, was measured by a
reaction with thiobarbituric acid (20). The quantifying
of reacted compounds with thiobarbituric acid was
determined by comparing the absorption of light rays
with a standard curve of TBARS equivalents formed by
hydrolysis of acid 1,1,3,3-tetramethoxypropane.
2.2.3. Activity of SOD in erythrocytes
Determination of SOD activity was carried out by means
of the method described by Beauchamp et al. (21), which
is based on binding of radicals present in the sample of
superoxide, generated by enzymatic reactions of xanthine
and xanthine oxidase via SOD, which is present in the
sample, by nitroblue tetrazolium. Finally, 600 µL of SOD
reaction mixture containing 0.1 mM xanthine, 0.1 mM
EDTA, 50 mg of bovine serum albumin, and 25 mmol/L
nitroblue tetrazolium was added to 125 µL of supernatant
or 125 µ: of standard solution of SOD, and subsequently 25
µL of 9.9 nM xanthine oxidase was added to each tube at
30-s intervals. Each sample was incubated for 20 min at 25
°C, and then the reaction was stopped by adding 0.5 mL of
0.8 mM solution of CuCl2 in 30-s intervals. The amount of
created formazan was determined spectrophotometrically
at the wavelength of 560 nm.
2.2.4. Protein concentration
Protein concentration was determined by the Lowry
method.
2.2.5. Activity of CAT in erythrocytes
The activity of CAT was determined by the Aebi method
(22), where the principle of analysis was based on the
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determination of constants of the decomposition rate
of hydrogen peroxide by CAT. The methodology of
determining the activity of CAT is as follows: 1 mL of 40
mM H2O2 was added to 2 mL of the sample in a phosphate
buffer (50 mM, pH 7.0, prepared by mixing 0.681 g of
KH2PO4 in 100 mL of distilled water and 1.335 g of Na2HPO4
× 2H2O in 150 mL of distilled water). Concentration
reduction of H2O2 was determined spectrophotometrically
at the wavelength of 240 nm for 3 min.
2.2.6. Activity of GPx in erythrocytes
The activity of GPx was determined at the wavelength of
340 nm by recording of NADPH concentration decrease.
The reaction mixture consisted of 50 mM potassium
phosphate buffer (pH 7.0), 1 mM EDTA, 1 mM sodium
azide (NaN3), 0.2 mM NADPH, 1 unit/mL GPx, 1 mM
GSH, and 0.25 mM H2O2. The source of the enzyme (0.1
mL of hemolyzed erythrocytes) was added to 0.8 mL of
this mixture, and the mixture was incubated at 25 °C 5 min
before the reaction start, which was caused by the addition
of 0.1 mL of hydrogen peroxide. Absorption of light rays at
the wavelength of 340 nm was recorded for 5 min. Activity
was calculated in µM GSH for 1 min per 1 g of protein.
2.2.7. Activity of glutathione reductase in erythrocytes
Glutathione reductase (GR) activity was determined
spectrophotometrically by the recovery speed of
glutathione in the presence of NADPH. The activity of GR
was determined in a reaction environment that contained
2 mL of phosphate buffer, 0.2 mL of EDTA, 0.5 mL of
oxidized glutathione, 0.2 mL of hemolysate, and 0.1 mL
of NADPH. Activity of the enzyme was determined by
the reduction of NADPH at 37 °C during 10 min with
a spectrophotometer at the wavelength of 340 nm. GR
activity was expressed in µM NADPH for 1 min per 1 g of
protein (23).
2.2.8. Concentration of GSH in erythrocytes
The concentration of GSH was measured by using
dithionitrobenzoate acid (DTNBA) and Ellman reagent.
The method was based on the formation of colored
products as a result of the 5.5-dithiobis-2-nitrobenzoate
acid reagent reaction and free sulfhydryl groups of
erythrocytes that absorb light rays at 412 nm.
One milliliter of sample was deprived of protein by
adding a solution containing 1.67 g of metaphosphoric
acid, 0.2 g of Na2EDTA, and 30 g of NaCl in distilled water.
Next, 2.4 mL of Na2HPO4 and 0.3 mL of DTNBA were
added to each sample, and the supernatant was purified by
centrifugation (10 min, 3000 rpm). The formed 5-thio-2nitrobenzoate acid was proportional to the concentration
of GSH, determined spectrophotometrically at the
wavelength of 412 nm and at 25 °C, in comparison with
the control samples.
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2.2.9. Determination of lysozymic activity of serum by
nephelometric method
Lysozymic activity was determined by the change
in optical density of microbial frozen Micrococcus
lysodeikticus under the influence of lysozyme test solution.
First, 0.03 mL of tested serum was added to 1.47 mL of
prepared Mc. lysodeikticus microbial culture flushing and
the mixture was incubated in a thermostat at 37 °C for
1 h. Nephelometry was conducted at the wavelength of
540 nm. Percentage of lysozyme activity was determined
by numerical parameters. To this end, percentage of
light penetration of initial microbial frozen (20%) was
calculated from the rate of studied frozen light penetration
(24).
2.2.10. Bactericidal activity of serum
Bacterial activity of serum is an integral indicator of the
natural humoral resistance, which indicates the ability
of blood to refine itself. Bactericidal activity of blood
in relation to microorganisms is associated with the
presence in serum of nonspecific protective components
(normal antibodies, lysozymes, complements, properdin,
interferon, bacterial lysines) and other factors. Flushes
from daily cultures of Escherichia coli were prepared
with saline, the density of which was determined by
photoelectrocolorimeter. One milliliter of investigated
serum was added to 4.5 mL of sterile meat peptone broth,
and in the control sample 1 mL of saline was used. One
drop of E. coli culture was then added to both samples.
To determine optical density, 2 mL from each sample was
taken. The remaining mixtures were incubated at 37 °C
for 3 h. Calculation of the results was done by finding the
difference between the final and initial optical densities
(25).
2.3. Statistical analysis
Statistical analysis was performed on statistically
significant differences between experimental groups by
dispersive analysis (one-way ANOVA) and Duncan test
using SPSS 10.1. The value of the results was ascertained at
P ≤ 0.05. Figures were prepared using Grapher 7.0 (Golden
Software Inc., USA).

3. Results
Results of the experiment indicated the influence of Cr(III)
availability on lipid peroxidation. Findings revealed that a
dose of 140 µg Cr3+/dm3 increased HPL concentration by
22.1%, while a dose of 70 µg Cr3+/dm3 decreased by 20.3%
(P ≤ 0.05) the concentration of TBARS in the blood of rats
in comparison with animals with no Cr(III) supply (Table
2).
Moreover, larger availability of Cr(III) caused changes
in the activity of antioxidant enzymes in the blood of rats
(Figure 1). In comparison with the control group, activity
of SOD in the blood of rats supplied with 70 and 140 µg
Cr3+/dm3 decreased by 1.6 and 2.6 times (P ≤ 0.01, Figure
1a), whereas activity of CAT increased by 1.27 (P ≤ 0.05,
Figure 1b) and 1.46 (P ≤ 0.01, Figure 1b) times, GPx by
1.12 and 1.21 times (P ≤ 0.01, Figure 1c), and GR by 1.28
(P ≤ 0.01) and 1.14 times (P ≤ 0.05, Figure 1d), respectively.
However, supplementation of Cr(III) did not increase
GSH concentration in the blood of rats significantly (P >
0.05, Figure 1d).
Administration of chromium to rats was also
accompanied by an increase of lysozymic and bactericidal
activity of blood serum (Table 3). Lysozymic activity
was definitely higher in the serum of rats treated with
chromium at doses of 70 and 140 µg Cr/dm3, by 17.0% (P
≤ 0.05) and 26.2% (P ≤ 0.01), respectively, and bactericidal
activity was respectively higher by 16.3% (P ≤ 0.05) and
26.2% (P ≤ 0.01) compared with animals not receiving
chromium.
4. Discussion
Although the essentiality of chromium in animal and
human nutrition is now well accepted, the recommended
intake is still under discussion because this element is
absorbed in the gastrointestinal tract at less than 3% (1).
For this reason, Yoshida et al. (26) indicated the lowest
adverse effect level of water Cr(III) supplementation to
be 100 µg/g Cr3+. However, in the discussed experiment,
changes in the antioxidant system of rats were observed

Table 2. Influence of accessibility of chromium on the content of lipid peroxidation (LPO) products in blood of rats (mean ± SE,
n = 10).

LPO products

Dose of chromium supplied in drink water
0 µg Cr/dm3

70 µg Cr/dm3

140 µg Cr/dm3

HPLs (ΔD480/mL)

0.73 ± 0.027a

0.70 ± 0.002a

0.57 ± 0.009b

TBARS-active products (nmol/mL)

7.29 ± 0.07a

6.13 ± 0.11b

7.59 ± 0.11a

Values in rows with different superscripted letters differ significantly at P ≤ 0.01.
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b)

A

10

Bc
b

8

12

CAT
[mmol/min × mg protein]

SOD
[% inhibition of formazan]

a)

B

8
C

4

Aa

6

4

2

0
0 µg

0

140 µg

70 µg

0 µg

Dose of chromium [Cr 3 - /dm3 ]

100

d)

GPx
[mmol/min × mg protein]

80

Bb

Ba
A

60

40

20

b

1.2
Aa

0.8

0.4

0

0
0 µg

14 0 µ g

7 0 µg

Dose of chromium
e)

14 0 µ g

1.6

Bb
GR
[nmol NADH+ /min × mg protein]

c)

70 µ g

Dose of chromium [Cr 3 - /dm3 ]

0 µg

70 µg

140 µg

Dose of chromium [Cr 3 - /dm3 ]

[Cr 3 - /dm3 ]
0.2

GSH
[mmol/dm3]

0.16

0.12

0.08

0.04

0
0 µg

70 µg

1 40 µg

Dose of chromium [Cr 3 - /dm3 ]

Figure 1. Activity of antioxidant enzymes: a) superoxide dismutase (SOD), b) catalase (CAT), c) glutathione peroxidase (GPx), d)
glutathione reductase (GR), and e) GSH concentrations in blood of rats water supplied with Cr(III) at doses of 0, 70, and 140 µg Cr3+/
dm3. A, B, C: bars with different uppercase letters differ significantly at P ≤ 0.01. a, b, c: bars with different lowercase letters differ
significantly at P ≤ 0.05.
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Table 3. Influence of accessibility of chromium on lysozymic and bactericidal activity of serum (mean ± SE, n = 10).

Activity of blood serum,%

Dose of chromium supplied in drinking water
0 µg Cr/dm3

70 µg Cr/dm3

140 µg Cr/dm3

Lysozymic

30.21 ± 0.86Aa

35.34 ± 1.80b

38.12 ± 1.34B

Bactericidal

41.53 ± 1.86Aa

48.29 ± 2.03b

52.40 ± 2.17B

A, B: values in rows with different uppercase letters differ significantly at P ≤ 0.01.
a, b: values in rows with different lowercase letters differ significantly at P ≤ 0.05.

in the case of both 70 and 140 µg Cr3+ addition. First, a
decrease of lipid peroxidation was observed. This is
consistent with the opinion that Cr(III) may be attributed
to participation in redox reactions (9). Redox reactions
are crucial for normal functioning and integrity of
cells and tissues in the organism (27). It is known that
the reaction to stress generates reactive oxygen forms,
including superoxide anion radicals (O2-), hydroxyl radicals
(HO-), and hydrogen peroxide (H2O2), which cause lipid
peroxidation, especially in membranes, and can cause
tissue damage (13). Therefore, chromium deficiency can
induce severe atherosclerosis and disrupt blood lipid
levels while Cr(III) supplementation can improve lipid
metabolism, decrease cholesterol content, and increase the
amount of triacylglycerols, which are less exposed to lipid
peroxidation due to their chemical structure (11). On the
other hand, Ścibior et al. (14) did not observe any changes
of lipid peroxidation caused by Cr supplementation.
This hypothesis can be supported by a decrease of
SOD activity, while an increase in activities of CAT, GPx,
and GR in erythrocytes of the blood of rats supplied with
Cr3+ was observed. It is well known that SOD is one of the
enzymes that interrupt the chain of oxygen-dependent
free-radical reactions in cells of aerobic organisms.
Therefore, enzyme activity is associated with intensity
of lipid peroxidation and depends on the amount of
intermediates accumulated in the tissue (28). It not only
prevents the development of free radical reactions and
accumulation of superoxide anions and peroxides but
also supports a high activity of redox processes (15,16).
By action of Cr3+, SOD activity decreases, as it is related
to the intensity of lipid peroxidation and depends on the
amount of accumulated intermediates in the tissue (16).
Simultaneously, there was an increase in the activity of
CAT, GPx, and GR, which participated in the reduction of
H2O2, a product of the reaction of SOD with active forms
of oxygen (free radicals) (16). Their increasing activity

may also result from regulatory effects of these enzymes
on gene expression (9). At the same time, stimulation of
defense is supported by increasing the GSH concentration
in the blood of rats supplied with chromium (29). This
is consistent with the observation of other authors who
established an increase of its content in the lungs of rats
with hyperlipidemia (30) or under the influence of vitamin
C synthesis with L-gulonic lactone in rats’ liver (8).
One of the important factors that testify to nutrition
value is the state of the immune system and its components.
Such indicators as bactericidal activity and lysozymic
serum activity, as well as humoral factors of nonspecific
resistance, show protective effect. It was found during
the experiment that Cr(III) supplementation can induce
higher resistance to the antigenic load, which is evidenced
by an increase of lysozymic and bactericidal activity. This
corresponds with the results of Şahin et al. (8) such that
total serum immunoglobulin levels in rabbits treated
with a higher dose of Cr(III) were growing. Moreover, a
number of other reports indicated a weakening of natural
resistance factors, which takes place in animals fed a
chromium-deficient diet (9). It is caused by deterioration
of membrane cells receptors’ activation to insulin, which
becomes less supplied with energy and functionally
weaker.
In general, the obtained results show that a diet
supplemented with chromium can strengthen the
main mechanisms of lipid peroxidation defense by
the stimulation of enzyme activity of the antioxidant
system and natural resistance factors. This proves the
indispensability of chromium supplied in animal nutrition
and emphasizes its particular biological role.
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